# Natural Products as Potentiators of β-Lactam Antibiotics: A Review of Mechanisms, Advances, and Future Directions

**Authors:** Wenjie Yang, Shuocheng Fan, Jie Luo, Yichu Zhou, Xingyang Dai, Jinhu Huang, Liping Wang, Xiaoming Wang

PMC · DOI: 10.3390/antiox15020154 · Antioxidants · 2026-01-23

## TL;DR

This review explores how natural products can enhance the effectiveness of β-lactam antibiotics to combat antibiotic resistance.

## Contribution

The paper systematically reviews mechanisms and strategies of natural products as antibiotic adjuvants, highlighting future directions.

## Key findings

- Natural products like flavonoids and clavulanic acid can inhibit β-lactamases and efflux pumps.
- Multi-omics and AI are proposed to accelerate the discovery of effective antibiotic adjuvants.
- In vitro and in vivo methods are essential for evaluating synergistic effects of natural products.

## Abstract

This review focuses on the research progress on natural products as β-lactam antibiotic adjuvants, aiming to address the escalating challenge of antibiotic resistance, particularly the inactivation of antibiotics caused by β-lactamases. The article provides an in-depth analysis of the mechanisms by which plant-derived (e.g., flavonoids, tannins, phenolics, terpenoids, and alkaloids) and microbial-derived (e.g., clavulanic acid, fungal metabolites, bacteriophages) natural products enhance antimicrobial efficacy. Key potentiation strategies discussed include efflux pump inhibition, membrane permeability alteration, biofilm disruption, PBP2a inhibition, and direct β-lactamase inhibition. Additionally, the review outlines in vitro methods (e.g., dilution and checkerboard assays) and in vivo models (e.g., mouse infection models) used to assess synergistic effects. It also addresses major challenges in identifying active compounds, elucidating mechanisms of action, and pharmacokinetic characterization. Looking forward, the article highlights the potential of multi-omics approaches, artificial intelligence, and nanotechnology to overcome existing bottlenecks, providing novel strategies for the development of effective and safe antibiotic adjuvants. These advances are expected to provide both theoretical insights and practical guidance for combating antibiotic-resistant bacterial infections.

## Linked entities

- **Chemicals:** clavulanic acid (PubChem CID 5280980)

## Full-text entities

- **Genes:** SMR [NCBI Gene 2598368], beta-Lactamase [NCBI Gene 13913583], KPC-2 [NCBI Gene 13914015]
- **Diseases:** VRE (MESH:D060467), injury to (MESH:D014947), inflammatory (MESH:D007249), pneumonia (MESH:D011014), infection (MESH:D007239), toxicity (MESH:D064420), Clostridium perfringens infection (MESH:D003015), MRSA (MESH:D013203), bacterial (MESH:D001424)
- **Chemicals:** polysaccharides (MESH:D011134), honokiol (MESH:C005499), lactam (MESH:D007769), Augmentin (MESH:D019980), Quercetin (MESH:D011794), ciprofloxacin (MESH:D002939), TF3 (MESH:C585473), beta-lactam antibiotics (MESH:D008997), ceftaroline (MESH:C490727), ginsenoside Rg3 (MESH:C097367), EGCG (MESH:C045651), Punicalagin (MESH:C115642), cefoxitin (MESH:D002440), galangin (MESH:C037032), EPS (MESH:C100219), 1,8-Cineole (MESH:D000077591), sugars (MESH:D000073893), AMP (MESH:D000089882), phosphate (MESH:D010710), piperacillin (MESH:D010878), zinc (MESH:D015032), MG (MESH:C052082), nitrocefin (MESH:C021720), oxygen (MESH:D010100), GA (MESH:D005707), plectasin (MESH:C504857), DMC (MESH:C050229), tobramycin (MESH:D014031), Alkaloids (MESH:D000470), liquiritigenin (MESH:C083152), fucoxanthin (MESH:C025164), amoxicillin (MESH:D000658), methicillin (MESH:D008712), lipid A (MESH:D008050), Glycyrrhizin (MESH:D019695), olivanic acids (MESH:C020786), lactivicin (MESH:C051231), curcuminoid (MESH:D036381), anisomycin (MESH:D000841), kaempferol (MESH:C006552), Cinnamaldehyde (MESH:C012843), vancomycin (MESH:D014640), carbapenem (MESH:D015780), penicillin G (MESH:D010400), TUN (MESH:D014415), ferulic acid (MESH:C004999), essential oil (MESH:D009822), tetracyclines (MESH:D013754), coumarin (MESH:C030123), Terpenoids (MESH:D013729), meropenem (MESH:D000077731), Cinnamic acid (MESH:C029010), Lignan (MESH:D017705), cephalosporins (MESH:D002511), proanthocyanidins (MESH:D044945), ceftriaxone (MESH:D002443), amino acids (MESH:D000596), triterpenoid (MESH:D014315), Tannic acid (MESH:D013634), hypericin (MESH:C004965)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Caenorhabditis elegans (species) [taxon 6239], Pseudomonas aeruginosa (species) [taxon 287], Klebsiella pneumoniae (species) [taxon 573], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Salmonella enterica subsp. enterica serovar Typhi (no rank) [taxon 90370], Candida albicans (species) [taxon 5476], Escherichia coli (E. coli, species) [taxon 562], Glycine max (soybean, species) [taxon 3847], Bacillus subtilis (species) [taxon 1423], Aspergillus sp. (species) [taxon 5065], Acalypha wilkesiana (species) [taxon 217498], Pseudomonas aeruginosa PAO1 (strain) [taxon 208964], Talaromyces piceae (species) [taxon 153982], Shigella dysenteriae (species) [taxon 622], Staphylococcus aureus (species) [taxon 1280], Mycobacterium tuberculosis (species) [taxon 1773], Streptomyces clavuligerus (species) [taxon 1901], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Empedobacter (genus) [taxon 59734], Staphylococcus epidermidis (species) [taxon 1282], Homo sapiens (human, species) [taxon 9606], Camellia (genus) [taxon 4441], Enterococcus faecium (species) [taxon 1352], Mycobacterium tuberculosis H37Ra (strain) [taxon 419947], Curcuma longa (turmeric, species) [taxon 136217], Enterobacteriaceae (enterobacteria, family) [taxon 543], Mentha (mints, genus) [taxon 21819], Aspergillus versicolor (species) [taxon 46472], Acinetobacter baumannii (species) [taxon 470]
- **Cell lines:** ATCC 43300 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12938352/full.md

## Figures

33 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12938352/full.md

## References

120 references — full list in the complete paper: https://tomesphere.com/paper/PMC12938352/full.md

---
Source: https://tomesphere.com/paper/PMC12938352